143 related articles for article (PubMed ID: 38616354)
21. The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia.
Piljić Burazer M; Mladinov S; Ćapkun V; Kuret S; Glavina Durdov M
Med Sci Monit; 2017 Jan; 23():489-497. PubMed ID: 28128193
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma.
Hurbin A; Wislez M; Busser B; Antoine M; Tenaud C; Rabbe N; Dufort S; de Fraipont F; Moro-Sibilot D; Cadranel J; Coll JL; Brambilla E
J Pathol; 2011 Sep; 225(1):83-95. PubMed ID: 21598249
[TBL] [Abstract][Full Text] [Related]
23. The predominant expression of hepatocyte nuclear factor 4α (HNF4α) in thyroid transcription factor-1 (TTF-1)-negative pulmonary adenocarcinoma.
Kunii R; Jiang S; Hasegawa G; Yamamoto T; Umezu H; Watanabe T; Tsuchida M; Hashimoto T; Hamakubo T; Kodama T; Sasai K; Naito M
Histopathology; 2011 Feb; 58(3):467-76. PubMed ID: 21348892
[TBL] [Abstract][Full Text] [Related]
24. [Clinicopathological characteristics and imaging features of pulmonary adenocarcinoma with micropapillary pattern].
Ren J; Zhou J; Ding W; Zhong B; Zhou J
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):282-6. PubMed ID: 24989915
[TBL] [Abstract][Full Text] [Related]
25. Presence of non-Newtonian fluid in invasive pulmonary mucinous adenocarcinomas impacts fluorescence during intraoperative molecular imaging of lung cancer.
Azari F; Kennedy G; Chang A; Nadeem B; Sullivan N; Marfatia I; Din A; Desphande C; Kucharczuk J; Delikatny EJ; Singhal S
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4406-4418. PubMed ID: 35876868
[TBL] [Abstract][Full Text] [Related]
26. Primary lung invasive adenocarcinoma misdiagnosed as infectious pneumonia in
Han Y; Luo Y
Radiol Case Rep; 2022 Mar; 17(3):808-811. PubMed ID: 35024081
[TBL] [Abstract][Full Text] [Related]
27. Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma.
Park J; Kobayashi Y; Urayama KY; Yamaura H; Yatabe Y; Hida T
PLoS One; 2016; 11(8):e0161081. PubMed ID: 27518729
[TBL] [Abstract][Full Text] [Related]
28. Evolution of lung adenocarcinoma from preneoplasia to invasive adenocarcinoma.
Zhu J; Wang W; Xiong Y; Xu S; Chen J; Wen M; Zhao Y; Lei J; Jiang T
Cancer Med; 2023 Mar; 12(5):5545-5557. PubMed ID: 36325966
[TBL] [Abstract][Full Text] [Related]
29. Individualized nomogram for predicting ALK rearrangement status in lung adenocarcinoma patients.
Song L; Zhu Z; Wu H; Han W; Cheng X; Li J; Du H; Lei J; Sui X; Song W; Jin ZY
Eur Radiol; 2021 Apr; 31(4):2034-2047. PubMed ID: 33146791
[TBL] [Abstract][Full Text] [Related]
30. [Bronchiolo-alveolar carcinoma. The computed tomographic picture and histological correlations].
Gaeta M; Volta S; Barone M; Caruso R; Loria G; Pandolfo I; Minutoli A
Radiol Med; 1994 Apr; 87(4):427-34. PubMed ID: 8190925
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary invasive mucinous adenocarcinoma.
Chang WC; Zhang YZ; Nicholson AG
Histopathology; 2024 Jan; 84(1):18-31. PubMed ID: 37867404
[TBL] [Abstract][Full Text] [Related]
32. ALK translocation is associated with ALK immunoreactivity and extensive signet-ring morphology in primary lung adenocarcinoma.
Popat S; Gonzalez D; Min T; Swansbury J; Dainton M; Croud JG; Rice AJ; Nicholson AG
Lung Cancer; 2012 Mar; 75(3):300-5. PubMed ID: 21855164
[TBL] [Abstract][Full Text] [Related]
33. Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings.
Nie K; Nie W; Zhang YX; Yu H
Cancer Imaging; 2019 Jul; 19(1):47. PubMed ID: 31292000
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical profiling of ALK fusion gene-positive adenocarcinomas of the lung.
Sakai Y; Nakai T; Ohbayashi C; Imagawa N; Yanagita E; Satake R; Nitta A; Kajimoto K; Sakuma T; Itoh T
Int J Surg Pathol; 2013 Oct; 21(5):476-82. PubMed ID: 23794492
[TBL] [Abstract][Full Text] [Related]
35. Pneumonic-type invasive mucinous adenocarcinoma and infectious pneumonia: clinical and CT imaging analysis from multiple centers.
Zhang S; Yu X; Huang Y; Nie P; Deng Y; Mao N; Li S; Zhu B; Wang L; Wang B; Wang X
BMC Pulm Med; 2022 Dec; 22(1):460. PubMed ID: 36461012
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and clinicopathological characteristics of ALK fusion subtypes in lung adenocarcinomas from Chinese populations.
Zheng D; Wang R; Zhang Y; Pan Y; Cheng X; Cheng C; Zheng S; Li H; Gong R; Li Y; Shen X; Sun Y; Chen H
J Cancer Res Clin Oncol; 2016 Apr; 142(4):833-43. PubMed ID: 26646246
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity.
Ko SJ; Lee YJ; Park JS; Cho YJ; Yoon HI; Chung JH; Kim TJ; Lee KW; Kim K; Jheon S; Kim H; Lee JH; Lee CT
BMC Cancer; 2014 May; 14():312. PubMed ID: 24885886
[TBL] [Abstract][Full Text] [Related]
38. Stepwise progression of invasive mucinous adenocarcinoma based on radiological and biological characteristics.
Goto E; Takamochi K; Kishikawa S; Hayashi T; Ueda T; Hattori A; Fukui M; Matsunaga T; Suzuki K;
Lung Cancer; 2023 Oct; 184():107348. PubMed ID: 37619407
[TBL] [Abstract][Full Text] [Related]
39. Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.
Hattori A; Suzuki K; Matsunaga T; Fukui M; Tsushima Y; Takamochi K; Oh S
Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):329-34. PubMed ID: 24351509
[TBL] [Abstract][Full Text] [Related]
40. CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas.
Han X; Fan J; Gu J; Li Y; Yang M; Liu T; Li N; Zeng W; Shi H
Cancer Imaging; 2020 Jul; 20(1):51. PubMed ID: 32690092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
